bupropion has been researched along with aripiprazole in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 17 (70.83) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dobkin, RD; Marin, H; Menza, MA | 1 |
| Sokolski, KN | 1 |
| Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W | 1 |
| Crayton, J; Nasr, S; Popli, A; Wendt, B | 1 |
| Baker, RA; Berman, RM; Cain, ZJ; Clayton, AH; Forbes, RA; Marcus, R; Marler, SV; Sheehan, JJ; Thase, ME | 1 |
| Chang, CC; Chang, HA; Chen, TY; Chu, CS; Tzeng, NS | 1 |
| Biswas, K; Chen, P; Davis, LL; Gerrity, M; Gleason, TC; Guarino, PD; Hicks, P; Huang, GD; Johnson, GR; Kelada, A; Kilbourne, AM; Kirkwood, KA; Lawrence, DD; LeGwin, M; Marder, S; Mohamed, S; Vertrees, JE; Weingart, K; Yoon, J; Young, IT; Zisook, S | 1 |
| Khouzam, HR | 1 |
| Chen, P; Davis, LL; Hicks, P; Huang, GD; Iranmanesh, A; Johnson, GR; Mohamed, S; Pilkinton, PD; Rao, S; Sapra, M; Tal, I; Vertrees, JE; Weingart, K; Wilcox, JA; Yoon, J; Zisook, S | 1 |
| Arandjelovic, K; Eyre, HA; Lavretsky, H | 1 |
| Baker, RA; Fava, M; Matsushima, Y; Okame, T; Perry, P; Weiller, E | 1 |
| Cheon, EJ; Koo, BH; Lee, JH; Lee, KH; Lee, SJ; Park, YW; Sung, HM | 1 |
| Albers, LJ; Anderson, KD; Anderson, WG; Aslam, M; Beresford, T; Carrera, CJ; Chen, P; Connolly, KR; D'Souza, DC; Davis, LL; Fareed, A; Fernando, R; Finkel, MS; Fischer, BA; Gleason, TC; Hicks, PB; Huang, GD; Hurley, R; Iranmanesh, A; Johnson, GR; Jones, KA; Juergens, TM; Jurjus, G; Kasckow, J; Khatkhate, G; Klatt, M; LaMotte, J; Larson, G; Lawrence, DD; Lieske, S; Little, JT; Loreck, DJ; Marri, S; Mayeda, AR; Michalets, JP; Mohamed, S; Nasdahl, CS; Niculescu, AB; Nogues, CA; Pilkinton, PD; Planeta, B; Ramaswamy, S; Rao, SD; Rosenlicht, N; Sapra, M; Scrymgeour, A; Suppes, T; Tal, I; Tapp, A; Thase, ME; Thompson, SI; Vertrees, JE; Villarreal, G; Weingart, K; Westermeyer, J; Wilcox, JA; Williams, SS; Winston, JL; Yoon, G; Yoon, J; Zisook, S | 1 |
| Aladeen, T; Capote, H; Lee, Y; McIntyre, RS; Rainka, M; Rong, C; Westphal, E | 1 |
| Johnson, GR; Mohamed, S; Park, A; Scrymgeour, A; Yoon, J; Zisook, S | 1 |
| Chen, P; Davis, L; Hicks, P; Johnson, GR; Mohamed, S; Tal, I; Thase, M; Vertrees, J; Zhao, Y; Zisook, S | 1 |
| Blumberger, DM; Brown, PJ; Cristancho, P; Karp, JF; Lavretsky, H; Lenard, E; Lenze, EJ; Miller, JP; Montes-Garcia, C; Mulsant, BH; Reynolds, CF; Rollman, BL; Roose, SP | 1 |
| Aslam, M; Chen, P; Davis, L; Hicks, PB; Iranmanesh, A; Johnson, GR; Jurjus, G; Lauro, K; Michalets, J; Mohamed, S; Pilkinton, P; Rao, SD; Sapra, M; Sevilimedu, V; Thase, M; Wilcox, JA; Zisook, S | 1 |
| Oravecz, R; Stuhec, M | 1 |
| Blumberger, DM; Brown, PJ; Cristancho, P; Flint, AJ; Gebara, MA; Gettinger, TR; Karp, JF; Lavretsky, H; Lenard, E; Lenze, EJ; Miller, JP; Mulsant, BH; Nicol, GE; Oughli, HA; Pham, VT; Reynolds, CF; Rollman, BL; Roose, SP; Yang, L | 1 |
| Ebell, MH | 1 |
4 review(s) available for bupropion and aripiprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy of methamphetamine addiction: an update.
Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Therapy; Humans; Lobeline; Methamphetamine; Methylphenidate; Narcotic Antagonists; Nicotinic Agonists; Piperazines; Prevalence; Quinolones; Recurrence; Substance-Related Disorders | 2008 |
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles | 2016 |
Bupropion XL unapproved use in the prisons: Two cases focused on the bupropion pharmacology.
Topics: Adult; Aripiprazole; Bupropion; Depressive Disorder, Major; Dopamine; Humans; Mirtazapine; Norepinephrine; Prisons; Quetiapine Fumarate; Randomized Controlled Trials as Topic | 2022 |
12 trial(s) available for bupropion and aripiprazole
| Article | Year |
|---|---|
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Bupropion; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Topics: Adult; Antidepressive Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Norepinephrine; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior; Treatment Outcome | 2014 |
The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Male; Remission Induction; Research Design; Time Factors | 2015 |
Characteristics of U.S. Veteran Patients with Major Depressive Disorder who require "next-step" treatments: A VAST-D report.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Aripiprazole; Bupropion; Comorbidity; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Middle Aged; United States; Veterans; Young Adult | 2016 |
Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.
Topics: Antidepressive Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Cognition; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Impulsive Behavior; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Sleep; Thiophenes; Treatment Outcome | 2017 |
Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dopamine Uptake Inhibitors; Drug Synergism; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Selective Serotonin Reuptake Inhibitors | 2017 |
Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Drug Resistance; Drug Substitution; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Remission Induction; United States; Veterans | 2017 |
Comparing Cost-Effectiveness of Aripiprazole Augmentation With Other "Next-Step" Depression Treatment Strategies: A Randomized Clinical Trial.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Aripiprazole; Bupropion; Cost-Benefit Analysis; Depression; Depressive Disorder, Major; Drug Substitution; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Remission Induction; United States; United States Department of Veterans Affairs; Veterans | 2018 |
General Predictors and Moderators of Depression Remission: A VAST-D Report.
Topics: Adult; Adverse Childhood Experiences; Aged; Aged, 80 and over; Antidepressive Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Drug Substitution; Drug Therapy, Combination; Employment; Female; Grief; Humans; Life Tables; Male; Middle Aged; Prognosis; Quality of Life; Remission Induction; Severity of Illness Index; Single-Blind Method; United States; United States Department of Veterans Affairs; Young Adult | 2019 |
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants Randomized.
Topics: Aged; Antidepressive Agents; Aripiprazole; Bupropion; Depressive Disorder, Treatment-Resistant; Humans; Lithium Compounds; Multicenter Studies as Topic; Nortriptyline; Pragmatic Clinical Trials as Topic; Treatment Outcome | 2019 |
Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial.
Topics: Adolescent; Adult; Antidepressive Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Single-Blind Method; Stress Disorders, Post-Traumatic; Young Adult | 2020 |
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression.
Topics: Aged; Antidepressive Agents; Aripiprazole; Bupropion; Depression; Drug Therapy, Combination; Humans; Lithium Compounds; Nortriptyline; Treatment Switching | 2023 |
8 other study(ies) available for bupropion and aripiprazole
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Adjunctive aripiprazole for bupropion-resistant major depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Bupropion; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones | 2008 |
Comparing outcomes of adjunctive treatment in depression: aripiprazole versus bupropion.
Topics: Adult; Antidepressive Agents; Aripiprazole; Bupropion; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Retrospective Studies | 2014 |
Killing two birds with one stone: the potential role of aripiprazole for patients with comorbid major depressive disorder and nicotine dependence via altering brain activity in the anterior cingulate cortex.
Topics: Antidepressive Agents, Second-Generation; Aripiprazole; Brain; Brain Diseases; Bupropion; Comorbidity; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Gyrus Cinguli; Humans; Nicotine; Serotonin; Smoking; Tobacco Use Disorder; Treatment Outcome | 2014 |
Clinicians' Views on Treatment-Resistant Depression: 2016 Survey Reports.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attitude of Health Personnel; Bupropion; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Psychiatry; Surveys and Questionnaires | 2016 |
The use of brexpiprazole amongst individuals with insufficient outcomes with aripiprazole or bupropion: A case series.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; New York; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies; Thiophenes; Treatment Outcome; Young Adult | 2018 |
Augmentation With Aripiprazole or Bupropion, or a Switch to Nortriptyline, Effective for Treatment-Resistant Depression in Older Adults.
Topics: Aged; Aripiprazole; Bupropion; Depression; Depressive Disorder, Treatment-Resistant; Humans; Nortriptyline | 2023 |